Artigo de periodico

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)

• Authors:
  • Bastard, Paul
  • Gervais, Adrian
  • Voyer, Tom Le
  • Rosain, Jérémie
  • Philippot, Quentin
  • Manry, Jérémy
  • Michailidis, Eleftherios
  • Hoffmann, Hans-Heinrich
  • Eto, Shohei
  • Garcia-Prat, Marina
  • Bizien, Lucy
  • Parra-Martínez, Alba
  • Yang, Rui
  • Liis, Haljasmägi
  • Migaud, Mélanie
  • Särekannu, Karita
  • Maslovskaja, Julia
  • Prost, Nicolas de
  • Tandjaoui-Lambiotte, Yacine
  • Luyt , Charles-Edouard
  • Amador-Borrero, Blanca
  • Alexandre, Gaudet
  • Poissy, Julien
  • Morel, Pascal
  • Richard, Pascale
  • Cognasse, Fabrice
  • Troya, Jesus
  • Trouillet-Assant, Sophie
  • Belot, Alexandre
  • Saker, Kahina
  • Garçon, Pierre
  • Rivière, Jacques G
  • Lagier, Jean-Christophe
  • Gentile, Stéphanie
  • Rosen, Lindsey B
  • Shaw, Elana
  • Morio, Tomohiro
  • Tanaka, Junko
  • Dalmau, David
  • Tharaux, Pierre-Louis
  • Sene, Damien
  • Stepanian, Alain
  • Megarbane, Bruno
  • Triantafyllia, Vasiliki
  • Fekkar, Arnaud
  • Heath, James R
  • Franco, José Luis
  • Anaya, Juan-Manuel
  • Solé-Violán, Jordi
  • Imberti, Luisa
  • Biondi, Andrea
  • Bonfanti, Paolo
  • Castagnoli, Riccardo
  • Delmonte, Ottavia M
  • Zhang, Yu
  • Snow, Andrew L
  • Holland, Steven M
  • Biggs, Catherine M
  • Moncada-Vélez, Marcela
  • Arias, Andrés Augusto
  • Lorenzo, Lazaro
  • Boucherit, Soraya
  • Coulibaly, Boubacar
  • Anglicheau, Dany
  • Planas, Anna M
  • Haerynck, Filomeen
  • Duvlis, Sotirija
  • Nussbaum, Robert L
  • Ozcelik, Tayfun
  • Keles, Sevgi
  • Bousfiha, Ahmed A
  • ElBakkouri, Jalila
  • Ramirez-Santana, Carolina
  • Paul, Stéphane
  • Pan-Hammarström, Qiang
  • Hammarström, Lennart
  • Dupont, Annabelle
  • Kurolap, Alina
  • Metz, Christine N
  • Aiuti, Alessandro
  • Casari, Giorgio
  • Lampasona, Vito
  • Ciceri, Fabio
  • Barreiros, Lucila A
  • Dominguez-Garrido, Elena
  • Vidigal, Mateus
  • Zatz, Mayana
  • Beek, Diederik van de
  • Sahanic, Sabina
  • Tancevski, Ivan
  • Stepanovskyy, Yurii
  • Boyarchuk, Oksana
  • Nukui, Yoko
  • Tsumura, Miyuki
  • Vidaur, Loreto
  • Tangye, Stuart G
  • Burrel, Sonia
  • Duffy, Darragh
  • Quintana-Murci, Lluis
  • Klocperk, Adam
  • Kann, Nelli Y
  • Shcherbina, Anna
  • Lau, Yu-Lung
  • Leung, Daniel
  • Coulongeat, Matthieu
  • Marlet, Julien
  • Koning, Rutger
  • Reyes, Luis Felipe
  • Chauvineau-Grenier, Angélique
  • Vene, Fabienne
  • Monneret, Guillaume
  • Nussenzweig, Michel C
  • Arrestier, Romain
  • Boudhabhay, Idris
  • Baris-Feldman, Hagit
  • Hagin, David
  • Wauters, Joost
  • Meyts, Isabelle
  • Dyer, Adam H
  • Kennelly, Sean P
  • Bourke, Nollaig M
  • Halwani, Rabih
  • Sharif-Askari, Narjes Saheb
  • Dorgham, Karim
  • Sallette, Jérome
  • Sedkaoui, Souad Mehlal
  • AlKhater, Suzan
  • Rigo-Bonnin, Raúl
  • Morandeira, Francisco
  • Roussel, Lucie
  • Vinh, Donald C
  • Ostrowski, Sisse Rye
  • Condino Neto, Antonio
  • Prando, Carolina
  • Bondarenko, Anastasiia
  • Spaan, András N
  • Gilardin, Laurent
  • Fellay, Jacques
  • Lyonnet, Stanislas
  • Bilguvar, Kaya
  • Lifton, Richard P
  • Mane, Shrikant
  • Anderson, Mark S
  • Boisson, Bertrand
  • Béziat, Vivien
  • Zhang, Shen-Ying
  • Andreakos, Evangelos
  • Hermine, Olivier
  • Pujol, Aurora
  • Peterson, Pärt
  • Mogensen, Trine
  • H Rowen, Lee
  • Mond, James
  • Debette, Stéphanie
  • Lamballerie, Xavier de
  • Duval, Xavier
  • Mentré, France
  • Zins, Marie
  • Soler-Palacin, Pere
  • Colobran, Roger
  • Gorochov, Guy
  • Solanich, Xavier
  • Susen, Sophie
  • Martinez-Picado, Javier
  • Raoult, Didier
  • Vasse, Marc
  • Gregersen, Peter K
  • Piemonti, Lorenzo
  • Rodríguez-Gallego, Carlos
  • Notarangelo, Luigi D
  • Su, Helen C
  • Kisand, Kai
  • Okada, Satoshi
  • Puel, Anne
  • Jouanguy, Emmanuelle
  • Rice, Charles M
  • Tiberghien, Pierre
  • Zhang, Qian
  • Cobat, Aurélie
  • Abel, Laurent
  • Casanova, Jean-Laurent
• USP affiliated authors: ZATZ, MAYANA - IB ; CONDINO NETO, ANTONIO - ICB ; BARREIROS, LUCILA AKUNE - IB ; CASTRO, MATEUS VIDIGAL DE - IB
• Unidades: IB; ICB
• DOI: 10.1126/sciimmunol.abl4340
• Subjects: COVID-19; INFECÇÕES POR CORONAVIRUS; ANTICORPOS; IMUNOLOGIA; HOMENS
• Agências de fomento:
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
    Processo FAPESP: 2020/09702-1
  • Financiamento NHGRI/CRGGH/NIH
  • Financiamento National Center for Advancing Translational Sciences
  • Financiamento ANR
  • Financiamento NEI/NIH
  • Financiamento DIR/NIAID/NIH
  • Financiamento ISCIII
  • Financiamento AMED
  • Financiamento NCI
  • Financiamento JBS S.A.
• Language: Inglês
• Imprenta:
  • Publisher place: Washington
  • Date published: 2021
• Source:
  • Título do periódico: Science Immunology
  • ISSN: 2470-9468
  • Volume/Número/Paginação/Ano: v. 6, n. 62, p. 1-30, 2021

Informações sobre o DOI: 10.1126/sciimmunol.abl4340 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: hybrid
• Licença: cc-by

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 18 abr. 2024.

• APA

  Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340

• NLM

  Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340

• Vancouver

  Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• The panorama in diagnoses of severe combined immunodeficiency begins to change in Brazil
• A novel homozygous JAK3 mutation leading to T-B+NK– SCID in two brazilian patients
• SCID and other inborn errors of immunity with Low TRECs — the Brazilian experience
• Investigação genético-molecular de pacientes com imunodeficiência combinada grave
• Fatores genéticos e imunológicos relacionados a Síndrome Congênita do Zika em humanos
• A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
• Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
• The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
• Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
• The 90 plus: longevity and COVID-19 survival